These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 27614848)

  • 1. Imaging of Triglycerides in Human Coronary Plaques by Color Fluorescent Angioscopy and Microscopy.
    Uchida Y; Uchida Y; Hiruta N; Shirai S; Yoshida T
    Am J Cardiol; 2016 Nov; 118(9):1306-1310. PubMed ID: 27614848
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular imaging of low-density lipoprotein in human coronary plaques by color fluorescent angioscopy and microscopy.
    Uchida Y; Maezawa Y; Uchida Y; Hiruta N; Shimoyama E
    PLoS One; 2012; 7(11):e50678. PubMed ID: 23209809
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recent Advances in Fluorescent Angioscopy for Molecular Imaging of Human Atherosclerotic Coronary Plaque.
    Uchida Y
    J Atheroscler Thromb; 2017 Jun; 24(6):539-551. PubMed ID: 28381766
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular imaging of apolipoprotein B-100 in human coronary plaques by color fluorescent angioscopy and microscopy.
    Hiruta N; Uchida Y; Maezawa Y; Shimoyama E; Uchida Y
    Int Heart J; 2013; 54(2):68-74. PubMed ID: 23676365
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fluorescent angioscopic imaging of calcium phosphate tribasic: precursor of hydroxyapatite, the major calcium deposit in human coronary plaques.
    Kobayashi T; Nakagawa O; Shirai S; Shimoyama E; Hiruta N; Uchida Y
    Int J Cardiovasc Imaging; 2017 Oct; 33(10):1455-1462. PubMed ID: 28432452
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Detection of vulnerable coronary plaques by color fluorescent angioscopy.
    Uchida Y; Uchida Y; Kawai S; Kanamaru R; Sugiyama Y; Tomaru T; Maezawa Y; Kameda N
    JACC Cardiovasc Imaging; 2010 Apr; 3(4):398-408. PubMed ID: 20394902
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Detection of Ceramide, a Risk Factor for Coronary Artery Disease, in Human Coronary Plaques by Fluorescent Angioscopy.
    Uchida Y; Uchida Y; Kobayashi T; Shirai S; Hiruta N; Shimoyama E; Tabata T
    Circ J; 2017 Nov; 81(12):1886-1893. PubMed ID: 28674269
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Localization of native high-density lipoprotein and its relation to plaque morphology in human coronary artery.
    Uchida Y; Hiruta N; Uchida Y; Shimoyama E
    Int Heart J; 2013; 54(6):348-54. PubMed ID: 24309443
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Imaging of native high-density lipoprotein in human coronary plaques by color fluorescent angioscopy.
    Uchida Y; Hiruta N; Yamanoi D; Shimoyama E; Maezawa Y; Uchida Y
    Circ J; 2014; 78(7):1667-75. PubMed ID: 24770335
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Visualization of lipid components in human coronary plaques using color fluorescence angioscopy.
    Uchida Y; Uchida Y; Kameda N
    Circ J; 2010 Oct; 74(10):2181-6. PubMed ID: 20736502
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular Imaging of Native Low-Density Lipoprotein by Near-Infrared Fluorescent Angioscopy in Human Coronary Plaques.
    Uchida Y; Yoshida T; Shimoyama E; Uchida Y
    Am J Cardiol; 2016 Mar; 117(5):781-6. PubMed ID: 26762728
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Localization of oxidized low-density lipoprotein and its relation to plaque morphology in human coronary artery.
    Uchida Y; Maezawa Y; Uchida Y; Hiruta N; Shimoyama E; Kawai S
    PLoS One; 2013; 8(2):e55188. PubMed ID: 23393566
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human pericoronary adipose tissue as storage and possible supply site for oxidized low-density lipoprotein and high-density lipoprotein in coronary artery.
    Uchida Y; Uchida Y; Shimoyama E; Hiruta N; Kishimoto T; Watanabe S
    J Cardiol; 2017 Jan; 69(1):236-244. PubMed ID: 27209423
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular imaging of native HDL in human coronary plaques by color fluorescent angioscopy.
    Uchida Y; Uchida Y; Hiruta N; Shimoyama E; Sugiyama E
    JACC Cardiovasc Imaging; 2013 Sep; 6(9):1015-7. PubMed ID: 23769490
    [No Abstract]   [Full Text] [Related]  

  • 15. Imaging of lysophosphatidylcholine in human coronary plaques by color fluorescence angioscopy.
    Uchida Y; Uchida Y; Kawai S; Kanamaru R; Kameda N
    Int Heart J; 2010 Mar; 51(2):129-33. PubMed ID: 20379048
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Topographic association of angioscopic yellow plaques with coronary atherosclerotic plaque: assessment with quantitative colorimetry in human coronary artery autopsy specimens.
    Ishibashi F; Lisauskas JB; Kawamura A; Waxman S
    Int J Cardiovasc Imaging; 2008 Jan; 24(1):1-5. PubMed ID: 17525866
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Implication of plaque color classification for assessing plaque vulnerability: a coronary angioscopy and optical coherence tomography investigation.
    Kubo T; Imanishi T; Takarada S; Kuroi A; Ueno S; Yamano T; Tanimoto T; Matsuo Y; Masho T; Kitabata H; Tanaka A; Nakamura N; Mizukoshi M; Tomobuchi Y; Akasaka T
    JACC Cardiovasc Interv; 2008 Feb; 1(1):74-80. PubMed ID: 19393149
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Histological characteristics of glistening yellow coronary plaques seen on angioscopy. -With special reference to vulnerable plaques-.
    Uchida Y; Uchida Y; Hiruta N
    Circ J; 2011; 75(8):1913-9. PubMed ID: 21670541
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vivo comparison of optical coherence tomography and angioscopy for the evaluation of coronary plaque characteristics.
    Takano M; Jang IK; Inami S; Yamamoto M; Murakami D; Okamatsu K; Seimiya K; Ohba T; Mizuno K
    Am J Cardiol; 2008 Feb; 101(4):471-6. PubMed ID: 18312760
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of the Effect of Rosuvastatin 2.5 mg vs 20 mg on Coronary Plaque Determined by Angioscopy and Intravascular Ultrasound in Japanese With Stable Angina Pectoris (from the Aggressive Lipid-Lowering Treatment Approach Using Intensive Rosuvastatin for Vulnerable Coronary Artery Plaque [ALTAIR] Randomized Trial).
    Takayama T; Komatsu S; Ueda Y; Fukushima S; Hiro T; Hirayama A; Saito S;
    Am J Cardiol; 2016 Apr; 117(8):1206-12. PubMed ID: 26879069
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.